The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance
Open Access
- 1 January 2024
- journal article
- review article
- Published by SAGE Publications in Cancer Control
- Vol. 31
Abstract
Background: Colorectal cancer is a major cause of mortality among the prevalent malignant tumors of the gastrointestinal tract. Although chemotherapy is a standard treatment for colorectal cancer, its efficacy is limited by chemoresistance. Recent studies have investigated targeting tumor stem cells as a potential new therapeutic approach for addressing chemoresistance in colorectal cancer. Colorectal cancer frequently relapses, with tumor stem cells often representing one of the leading causes of treatment failure. Purpose: Understanding drug resistance in colorectal cancer stem cells is crucial for improving treatment outcomes. By focusing on developing targeted therapies that specifically address drug resistance in colorectal cancer stem cells, there is potential to make significant advancements in the treatment of colorectal cancer.This approach may lead to more effective and lasting outcomes in patients battling colorectal cancer. Research Design: In this review, a comprehensive overview of recent research on colorectal cancer stem cell treatment resistance is presented.Results: Elucidating the key underlying mechanisms. This review also highlights the potential benefits of targeted therapies in overcoming colorectal cancer resistance to treatment. Conclusions: CCSCs are key players in drug resistance of CRC, indicating their potential as targets for effective therapy. Elucidating their role in this process could aid in discovering tailored treatment strategies.The significance of signaling pathways, TME, and miRNA in regulating drug resistance in CCSCs is been highlighted.Keywords
Funding Information
- Jiangxi University of Traditional Chinese Medicine School-level Science and Technology Innovation Team Development Program Project (No.CXTD22011)
- Jiangxi Provincial Traditional Chinese Medicine Youth Key Talents (the Fourth Tranche) Training Program (Gan Traditional Chinese Medicine Science and Education 2022 No.7)
- National Natural Science Foundation of China (82160925, 82205221)
- Natural Science Foundation of Jiangxi Province (20224BAB206097)
This publication has 189 references indexed in Scilit:
- Hedgehog signaling maintains a tumor stem cell compartment in multiple myelomaProceedings of the National Academy of Sciences, 2007
- The Bcl-2 apoptotic switch in cancer development and therapyOncogene, 2007
- Hedgehog signaling pathway and gastrointestinal stem cell signaling network (Review)International Journal of Molecular Medicine, 2006
- Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell HypothesisThe Journal of Clinical Pharmacology, 2005
- Mammary stem cells, self-renewal pathways, and carcinogenesisBreast Cancer Research, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- Constitutive activation of Stat3 signaling pathway in human colorectal carcinomaWorld Journal of Gastroenterology, 2004
- Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell DeathJournal of Clinical Oncology, 1999
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997